raloxifene hydrochloride has been researched along with risperidone in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
| Akhondzadeh, S; Fatehi, F; Hashempoor, S; Kashani, L; Khodaei-Ardakani, MR; Kianimehr, G; Nazari, A; Rezaei, F | 1 |
| Akhondzadeh, S; Khodaie-Ardakani, MR; Khosravi, M; Mohsenian, A; Nejati, S; Tabrizi, M; Zarinfard, R | 1 |
2 trial(s) available for raloxifene hydrochloride and risperidone
| Article | Year |
|---|---|
Raloxifene adjunctive therapy for postmenopausal women suffering from chronic schizophrenia: a randomized double-blind and placebo controlled trial.
Topics: Aged; Antipsychotic Agents; Chronic Disease; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Middle Aged; Postmenopause; Psychiatric Status Rating Scales; Raloxifene Hydrochloride; Risperidone; Schizophrenia; Selective Estrogen Receptor Modulators; Treatment Outcome | 2014 |
A Placebo-Controlled Study of Raloxifene Added to Risperidone in Men with Chronic Schizophrenia.
Topics: Adult; Antipsychotic Agents; Depression; Double-Blind Method; Drug Therapy, Combination; Humans; Male; Psychiatric Status Rating Scales; Raloxifene Hydrochloride; Risperidone; Schizophrenia; Treatment Outcome; Young Adult | 2015 |
2 other study(ies) available for raloxifene hydrochloride and risperidone
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |